Basel, 6 - 8 October 2025
Schedule
Create your personal agenda –check the favourite icon
Oct 69:00
Conference pass
Oct 611:40
Conference pass
Chair's remarks
Population Genomics
Kate Witkowska, Strategic Partnerships Director, Genomics England
Oct 611:40
Conference pass
Chair's remarks
Population Genomics
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Oct 611:40
Conference pass
Chair's remarks
AI in Drug Development and Discovery
Franck Augé, Director R&D Search and Evaluation AI and Digital Technologies, Servier
Oct 611:40
Conference pass
Chair's remarks
Cheminformatics
Werngard Czechtizky, Executive Director Head of Medicinal Chemistry, AstraZeneca
Oct 611:40
Conference pass
Chair's remarks
AI in Clinical Trials
Rana Abou Antoun, Global Commercial Director Cell and Gene, Novartis
Oct 611:45
Conference pass
Population Genomics from a Novartis perspective
Population Genomics
Abhishek Dhanuka, Team lead, Novartis
Oct 611:45
Conference pass
Integrating and contextualizing multi-modal data for advancing personalized medicine
AI in Drug Development and Discovery
Carine Poussin, Head of AI for Life Sciences, CSEM
Oct 611:45
Conference pass
Predictive & Generative Modelling in Drug Design Opportunities and Challenges of Augmented Intelligence
Cheminformatics
Nils Weskamp, Associate Director Computational Chemistry / Data Science, Boehringer Ingelheim Pharma GmbH & Co. KG
Oct 611:45
Conference pass
AI immunology: a new era in vaccine discovery
Bioinformatics + In silico R&D
Andreas Holm Mattsson, Chief AI Officer, Evaxion Biotech
Oct 611:45
Conference pass
Upscaling for future pharma fit processes
LLMs
Carolina Benjaminsen, Senior Director and Head of Digital Science Academy for R&ED, Novo Nordisk
Oct 611:45
Conference pass
Machine learning and multi-modal data for target discovery and patient understanding
Big Data in Oncology
Sina Nassiri, Principal Bioinformatics Scientist, Roche Pharma
Oct 611:45
Conference pass
From silo projects to digital landscape
Digital Transformation
Claudia Vogt, Chief of Staff R&D Data Science & AI, Bayer AG
Oct 611:45
Conference pass
5 new ways to sabotage your R&D data platform
Data Management, Storage and Architecture
Maks Shah, Head Data Design Authority, Syngenta Crop Protection
Oct 611:45
Conference pass
Advanced meta data exchange for healthcare
Data Integration + FAIR
Steffen Vogler, Senior Imaging Technology Scientist, Bayer
Oct 611:45
Conference pass
Advanced gut-on-a-chip platform for therapeutic target identification
Analytics Platform
Paul Wilmes, Full Professor of Systems Ecology, University of Luxembourg
Oct 611:45
Conference pass
Real world evidence at a tertiary children’s hospital
Real World Evidence
Catherine Brownstein, Assistant Professor, Harvard Medical School
Oct 612:25
Conference pass
Enabling clinical genomics at National scale
Population Genomics
James Duboff, Strategic Partnerships Director, Genomics England
Oct 612:25
Conference pass
ML in drug discovery
AI in Drug Development and Discovery
Damian Roqueiro, Senior Scientist, Roche
Oct 612:25
Conference pass
Application of LLM in drug discovery
Cheminformatics
Werngard Czechtizky, Executive Director Head of Medicinal Chemistry, AstraZeneca
Oct 612:25
Conference pass
Event driven architecture for HT proteomics
Bioinformatics + In silico R&D
Francisco Bonachela Capdevila, TPO High Dimensional Biology and Bioinformatics,, JNJ
Oct 612:25
Conference pass
Integrating Single-Cell Multi-Omics into Clinical Trials: Paving the Way for Precision Medicine and Biomarker Discovery
Single Cell Genomics
Vivek Das, Lead Data Scientist, AI and Analytics, Novo Nordisk
Oct 612:25
Conference pass
AI agents for translational medicine
LLMs
Oct 612:25
Conference pass
Identification of small molecules targeting rna
Big Data in Oncology
Antoine de Weck, Group Leader, Children's cancer Institute
Oct 612:25
Conference pass
Patient finding
Digital Transformation
Oct 612:25
Conference pass
FAIR In-vivo data Sharing: Enabling in-vivo workflows using a FAIR by design platform
Data Integration + FAIR
Anastasios Moresis, Principal Scientist Data Products and Platforms, Roche
Oct 612:25
Conference pass
Accelerating ML Deployment: Operationalizing Kubeflow for Scalable Drug Discovery at Roche
Analytics Platform
Malgorzata Bartosik, Senior IT Professional Data Science, Roche Polska Sp. Zoo
Oct 612:25
Conference pass
Boosting clinical data management with genAI
AI in Clinical Trials
Ercan Suekuer, Senior AI Clinical Data Scientist, Roche
Oct 612:25
Conference pass
RWE at UCB
Real World Evidence
Johann de Jong, Associate Director, Global Advanced Analytics, UCB Pharma
Oct 613:05
Conference pass
Genomeasia 100K
Population Genomics
Hie Lim Kim, Assistant Professor, Asian School of Environment, NTU Singapore
Oct 613:05
Conference pass
Early involvement of patients in clinical trials to develop innovative treatments (Gene Therapies)
AI in Drug Development and Discovery
Theodora Weisz, Head of Patient Advocacy and Public Affairs, Novartis Gene Therapies, Novartis Gene Therapies
Oct 613:05
Conference pass
The OpenChemLib: Powering Cheminformatics at Idorsia
Cheminformatics
Oct 613:05
Conference pass
In silico and bioinformatics application in drug safety
Bioinformatics + In silico R&D
Oct 613:05
Conference pass
Single Cell Analysis in the Age of AI
Single Cell Genomics
Oct 613:05
Conference pass
Power of LLMs in pre clinical drug discovery
LLMs
Shayoni Dutta, Data Science Manager, GlaxoSmithKline
Oct 613:05
Conference pass
Integrative longitudinal functional genomics To Identify Novel treatment Induced Cancer Vulnerabilities
Big Data in Oncology
Simon McDade, Professor of Functional Genomics, Queen's University Belfast
Oct 613:05
Conference pass
Digital transformation in bacteriology
Digital Transformation
Oct 613:05
Conference pass
Journey to democratise data: the good, the bad, the ugly
Data Management, Storage and Architecture
Pierre Fischer, Product Line Lead Data Platforms, F. Hoffmann-La Roche Ltd
Oct 613:05
Conference pass
Connecting the dots between Analytics platform and pharma
Analytics Platform
Lana Ghanem, Managing Director, Hikma Ventures/VP of Digital Health & Life Sciences Investements, Hikma Pharmaceuticals
Oct 613:05
Conference pass
Digital twin for clinical trials
AI in Clinical Trials
Benjamin Gmeiner, Director and Head of Medical Data Strategy & Science, Novartis Pharma
Oct 613:05
Conference pass
AI in RWD
Real World Evidence
Abhishek Choudhary, Principal Data Engineer, Bayer AG
Oct 614:25
Conference pass
Chair's remarks
AI in Drug Development and Discovery
Caroline Gubser Keller, Global Head Data Science -Discovery Sciences, Novartis Biomedical Research
Oct 614:25
Conference pass
Chair's remarks
Cheminformatics
David Drake, Drug Discovery IT Capability Lead, AstraZeneca
Oct 614:25
Conference pass
Chair's remarks
Bioinformatics + In silico R&D
Derya Aytan-Aktug, Senior Bioinformatics Scientist, Leo Pharma
Oct 614:25
Conference pass
Chair's remarks
Single Cell Genomics
Zhongyi Wang, Senior Expert II Data Science, Novartis
Oct 614:25
Conference pass
Chair's remarks
Analytics Platform
Alfred Stefan, Manager LU Informatics, AbbVie
Oct 614:30
Conference pass
Harnessing AI for Drug Discovery to Accelerate, Enhance, and Innovate
AI in Drug Development and Discovery
Caroline Gubser Keller, Global Head Data Science -Discovery Sciences, Novartis Biomedical Research
Oct 614:30
Conference pass
Drug Development Data Platform and In Silico R&D
Bioinformatics + In silico R&D
Echedey Lorenzo, Lead Data Engineer, Research Data Platform, AstraZeneca
Oct 614:30
Conference pass
Leveraging single cell and spatial transcriptomics for target discovery
Single Cell Genomics
Zhongyi Wang, Senior Expert II Data Science, Novartis
Oct 614:30
Conference pass
The ”Majority Illusion” in DLBCL Lessons we have learned from social media help us identify cancer’s biomarkers
Big Data in Oncology
Luciano Cascione, Head of Bioinformatics Core Unit, Institute of oncology research (IOR),
Oct 614:30
Conference pass
KM applied to digital transformation
Digital Transformation
Stefano Dal Santo, Head of Knowledge Management, Novartis
Oct 614:30
Conference pass
Preparing biomedical research data landscape to be AI ready
Data Management, Storage and Architecture
Ralph Haffner, VP Research Informatics, Novartis, Biomedical Research
Oct 614:30
Conference pass
FAIR meta data management to accelerate data integration and insight generation
Data Integration + FAIR
Martin Romacker, Product Manager – Roche Data Marketplace, Roche
Oct 614:30
Conference pass
Operational simulation framework for internal programme modelling
Analytics Platform
Jin Hyun Ju, Director of Data Science, BridgeBio
Oct 614:30
Conference pass
Unlocking the potential of hERVs as vaccine antigens
AI in Clinical Trials
Jens Kringelum, VP, AI & Innovation, Evaxion Biotech
Oct 614:30
Conference pass
Oct 615:10
Conference pass
Generative Chemistry
AI in Drug Development and Discovery
Antoine Taly, Researcher, CNRS
Oct 615:10
Conference pass
In silico darpin therapeutics
Bioinformatics + In silico R&D
Ana Filipa Fonseca, Director, Global RLT Strategy & Early Portfolio, Novartis
Oct 615:10
Conference pass
Decoding the regulatory genome through multi-omics integration to identify novel non-coding RNA targets
Single Cell Genomics
Oct 615:10
Conference pass
LLMs across pharma value chain
LLMs
Waheed Jowiya, Digitalisation Strategy Lead, Novo Nordisk
Louise Lind Skov, Director of Content Digitalisation, Novo Nordisk
Oct 615:10
Conference pass
Accelerating clinical trials using AI
Big Data in Oncology
Oct 615:10
Conference pass
Digital services with medical products
Digital Transformation
Oct 615:10
Conference pass
Navigating the Data Fabric: Debiopharm's Journey to Mastering Clinical and Pre-Clinical Data
Data Management, Storage and Architecture
Frederico Braga, Head of Digital and IT, Debiopharm
Oct 615:10
Conference pass
Sharing antiviral discovery data to accelerate therapeutic discovery
Data Integration + FAIR
Oct 615:10
Conference pass
The shift of Analytics Platforms and organizations in light of AI
Analytics Platform
Oct 615:10
Conference pass
Generative AI & the Importance of Having a Well Crafted Data Strategy
AI in Clinical Trials
Oct 615:10
Conference pass
Impact of RWE in cannabinoids based medicines
Real World Evidence
Ana Serrato, Head Clinical Development, Avextra
Oct 615:30
Conference pass
Broadening precision medicine through pharmacogenomics
Population Genomics
Oct 615:50
Conference pass
Exploratory rare variant analysis in neurodegeneration using AI within UK Biobank and clinical trials
Population Genomics
Achim Kless, Senior Director Pain Genetics, Eli Lilly and Company
Oct 615:50
Conference pass
Getting decision makers invested in AI at GSK
AI in Drug Development and Discovery
Peter Richard Martin, Director, GSK
Oct 615:50
Conference pass
Data driven approach to Targeted glues drug discovery
Bioinformatics + In silico R&D
Liliana Greger, Senior Director of Bioinformatics, Amphista Therapeutics
Oct 615:50
Conference pass
LLMs at Bayer
LLMs
Jordi Casanellas, Head of Language AI, Bayer
Oct 615:50
Conference pass
Digital transformation & Pharma GTM model
Digital Transformation
Barbara Albientz, Chief Commercial Officer, Helvion Pharma
Oct 615:50
Conference pass
Transform genomic and biological data into insights
Data Management, Storage and Architecture
Kortine Kleinheinz, Digital Lead for Research IT, Bayer AG
Oct 615:50
Conference pass
Swiss personalised health network
Data Integration + FAIR
Sabine Österle, Lead Sematic Interoperability Strategy and FAIR Data Team, SIB Swiss Institute of Bioinformatics
Oct 615:50
Conference pass
Building a group wide-data platform
Analytics Platform
Christophe Chabbert, Group Lead, Data & AI, Octapharma Biopharmaceuticals GmbH
Oct 615:50
Conference pass
Smartly applying AI to improve access to medicines
AI in Clinical Trials
Alexander Krupp, Innovation Lead, Clinical Development and Operations, Bayer
Oct 615:50
Conference pass
NHS secured data environments for RWE generation
Real World Evidence
Adrian Jonas, Chief Analyst for the North West Region, NHS
Oct 616:40
Conference pass
Chair's remarks
AI in Drug Development and Discovery
John Wise, Consultant, Pistoia Alliance
Oct 616:45
Conference pass
Developing Integrated Risk Scores for Cardiovascular Disease Prediction
Population Genomics
Panagiotis Deloukas, Director of William Harvey Institute,, Queen Mary University of London
Oct 616:45
Conference pass
Applied AI use cases in drug discovery and development
AI in Drug Development and Discovery
Anna Fournier, Principal Data Scientist, Swiss Data Science Center
Oct 616:45
Conference pass
Chemistry with Artificial Intelligence
Cheminformatics
Rolf Jautelat, VP R&D Data Science & AI, Bayer
Oct 616:45
Conference pass
Computational approaches for target discovery
Bioinformatics + In silico R&D
Becky Saunders, Associate Director, Computational Biologist, E-therapeutics
Oct 616:45
Conference pass
Drug Discovery
Single Cell Genomics
Ulrike Naumann, Director Genomics, Novartis
Oct 616:45
Conference pass
How we utilise generative AI at Novo Nordisk
LLMs
Peter Vester, Lead Data Scientist, Novo Nordisk
Oct 616:45
Conference pass
Digital Transformation in pharmaceutical Manufacturing
Digital Transformation
Frank Thielmann, Head Function of the Future, Takeda
Oct 616:45
Conference pass
Data products and data marketplace success stories
Data Management, Storage and Architecture
Gaurav Grigo, Sr. Director, Head of Architecture & Systems Engineering, DDIT-R&ED, Novo Nordisk
Sandeep Majumder, Head of Data Management and Solutions, Novo Nordisk
Oct 616:45
Conference pass
Drug Development Data Platform and Data Integration + FAIR
Data Integration + FAIR
Ander Sainz Loyola, Lead Data Engineer, Research Data Platform, AstraZeneca
Oct 616:45
Conference pass
Microbial Genomics platform
Analytics Platform
Tim Roloff, Co Department Head Microbial Genomics, University of Zurich
Oct 616:45
Conference pass
Transforming Clinical Research with AI Agents
AI in Clinical Trials
Georgios Kavousanos, Senior AI Engineer, Novo Nordisk
Oct 616:45
Conference pass
AI agents for Evidence Generation
Real World Evidence
Thirupathi Pattipaka, Global Director, Data Science and AI, Novartis
Oct 617:25
Conference pass
Panel discussion: Summary Panel Population Genomics
Population Genomics
Moderator: Kate Witkowska, Strategic Partnerships Director, Genomics England
Oct 617:25
Conference pass
Panel discussion: From Data to Diagnosis: The Power of Multi-Omics in Clinical Research
Bioinformatics + In silico R&D
Moderator: Ornella Cominetti, Senior Omics Data Specialist, Nestlé
Oct 617:25
Conference pass
Panel discussion: Are LLMs enough?
LLMs
Aleksandar Kapisoda, Digital Business Analyst, Boehringer Ingelheim
Jacek Domanski, Director of Enterprise Innovation Tech, GSK
Oct 617:25
Conference pass
Turning Data into Action: Integrating Processes Analytically
Analytics Platform
Moderator: Francesco Orsi, Data Science Manager, Roche
Oct 617:25
Conference pass
Panel discussion: Digital Twins in Drug Development: Accelerating Clinical Trial Timelines
AI in Clinical Trials
Mara Hummel, Sr Clinical Operations Lead, Hoffmann-La Roche Ltd.
Oct 617:25
Conference pass
Panel discussion: Elevate health – improving patient care
Real World Evidence
Moderator: Petra Nathan, Global Head of Implementation Science, Boehringer Ingelheim
Michael Rebhan, Associate Director, Translational Research DS, Novartis
Create your personal agenda –check the favourite icon
Oct 711:45
Conference pass
Chair's remarks
Digital Transformation
Maya Shevlyakova, Associate Director Global Digital Core, CSL Behring AG
Oct 711:45
Conference pass
Chair's remarks
Data Integration + FAIR
Oct 711:45
Conference pass
Chair's remarks
AI in Clinical Trials
Philipp Pauli, Country Head Oncology Germany, Takeda
Oct 711:45
Conference pass
Chair's remarks
Precision Medicine, Diagnostics and Therapies
Maria Guerrero, EMEA Product manager, Janssen
Oct 711:45
Conference pass
Oct 711:45
Conference pass
Chair's remarks
Quantum Pharma
John Wise, Consultant, Pistoia Alliance
Oct 711:50
Conference pass
Enabling AI drug development with AI capabilities
AI in Drug Development and Discovery
Deepak Sondur, Domain Lead Digital Products Enablement, Roche
Oct 711:50
Conference pass
Discovery and engineering of next-gen immunotherapies with EMLy Co-pilot
Bioinformatics + In silico R&D
Jacob Hurst, Chief Technology Officer, Etcembly
Oct 711:50
Conference pass
Realising value of digital transformation a real-world example
Digital Transformation
Waheed Jowiya, Digitalisation Strategy Lead, Novo Nordisk
Oct 711:50
Conference pass
Before Gen AI, Get Your Data Right: Why FAIR Data Matters
Data Integration + FAIR
Oct 711:50
Conference pass
R&D analytics at your fingertips: the CSL scientific app store
Analytics Platform
Carmen Weber, Manager Data Excellence, CSL Behring
Oct 711:50
Conference pass
AI driven trial design and trial planning
AI in Clinical Trials
Jeremy Zhang, Sr Director, Advanced Analytics, Gilead Sciences
Oct 711:50
Conference pass
AI for RWE
Real World Evidence
Oct 711:50
Conference pass
Foundational model for medical imaging
Image Analysis
Sadegh Mohammadi, Head of Computer Vision & Sound Analysis, Bayer AG
Oct 711:50
Conference pass
End to end automation of laboratory workflows
Lab Automation
Felix Stemmer, Senior Scientist II, Novartis Pharma AG
Oct 711:50
Conference pass
Demonstration of quantum utility for pharma use case
Quantum Pharma
Clément Javerzac-Galy, Professor, group leader, FHNW
Oct 712:30
Conference pass
Deciphering immune landscape with AI
AI in Drug Development and Discovery
Oct 712:30
Conference pass
DigiMab: in-silico Antibody Discovery Platform
Bioinformatics + In silico R&D
Irem Nasir, R&D Engagement Lead, Sr. Data Scientist, Bayer
Oct 712:30
Conference pass
Increasing operational efficiencies: Driving Digital Adoption with Product Analytics
Digital Transformation
Liselle Mulcaire, Digital Product Operations, Development Digital Transformation, Novo Nordisk
Oct 712:30
Conference pass
Big Data in FAIR implementation from an international perspective
Data Integration + FAIR
Zisis Kozlakidis, Head of Laboratory Services and Biobanking, World Health Organization / International Agency For Research on Cancer
Oct 712:30
Conference pass
Data Science under One Roof OCEAN & NextGen @ Roche PD Data Sciences
Analytics Platform
Helene Royo, Senior Principal Data Science Product Leader, Roche
Oct 712:30
Conference pass
iQNow AI enabled approach to knowledge management
AI in Clinical Trials
Aleksandar Kapisoda, Digital Business Analyst, Boehringer Ingelheim
Oct 712:30
Conference pass
Elevate health open science initiative
Real World Evidence
Michael Rebhan, Associate Director, Translational Research DS, Novartis
Oct 712:30
Conference pass
Unlocking the potential of cell-free RNA for liquid biopsy biomarker and diagnostics
Precision Medicine, Diagnostics and Therapies
Bogdan Mateescu, group leader, University of Zurich
Oct 712:30
Conference pass
Image analysis in cryoEM to rationalise drug discovery
Image Analysis
Alexey Rak, Department Head, Bio Structure and Biophysics Integrated Drug Discovery,, Sanofi
Oct 712:30
Conference pass
IT Landscape and Robotics in the lab
Lab Automation
Jiayi Tong, Data Engineer, Roche
Oct 712:30
Conference pass
Applications and comparisons of pharmaceutical quantum computing
Quantum Pharma
Johannes Galatsanos, Researcher at Center of Quantum Networks, Massachusetts Institute of Technology
Oct 713:10
Conference pass
Utilising multimodal data in early drug development
AI in Drug Development and Discovery
Matthias Orlowski, Principal ML Engineer, Bayer AG
Oct 713:10
Conference pass
Early target assessment
Bioinformatics + In silico R&D
Oct 713:10
Conference pass
The next steps towards customer centricity
Digital Transformation
Michael Zaiac, Head of Medical Affairs Oncology Europe and Canada, Daiichi Sankyo
Oct 713:10
Conference pass
FAIR Knowledge Graphs, benefits and challenges
Data Integration + FAIR
Oct 713:10
Conference pass
Sevier’s analytics platform
Analytics Platform
Thibaut Snollaerts, Senior Manager, Pre-clinical Data Management, Servier
Oct 713:10
Conference pass
Enhancing Drug Development: The Role of Digital Biomarkers in Clinical Trials
AI in Clinical Trials
Thanneer Perumal, Senior Principal Scientist, Roche
Oct 713:10
Conference pass
Evidence generation in early-stage drug development
Real World Evidence
Moritz Saxenhofer, Senior Manager Translational Research, CSL Behring
Oct 713:10
Conference pass
Approaches to precision therapeutics and clinical trial enhancements
Precision Medicine, Diagnostics and Therapies
Mary Helen Black, SVP and Head of Genomics, Foresite Labs
Oct 713:10
Conference pass
Phenomic immune-health profiling through self-supervised representation learning
Image Analysis
Oct 713:10
Conference pass
Exploring the Quantum challenges and impact in pharma
Quantum Pharma
Benoit Lelong, Head of Group Data Platform, Servier
Oct 714:30
Conference pass
Chair's remarks
AI in Clinical Trials
Philipp Pauli, Country Head Oncology Germany, Takeda
Oct 714:30
Conference pass
Chair's remarks
Real World Evidence
Diar Fattah, Global Director, Innovative Value Strategies And Evidence (Respiratory), AstraZeneca
Oct 714:30
Conference pass
Chair's remarks
Precision Medicine, Diagnostics and Therapies
Giovanni Rizzo, Partner Biotech Fund, Indaco Venture Partners
Oct 714:35
Conference pass
How to optimize AI quality methods to utilize prior knowledge
AI in Drug Development and Discovery
Etzard Stolte, Global Head Of Knowledge Management Ptd, Roche
Oct 714:35
Conference pass
Sabah Nature Wonders: For Sustainable Drug Development
Bioinformatics + In silico R&D
Syahriel Abdullah, Senior Lecturer / Researcher, Universiti Malaysia Sabah (UMS)
Oct 714:35
Conference pass
Oct 714:35
Conference pass
Advancing OCT Analysis in nAMD and DR/DME Treatment
Analytics Platform
Christina Pamela Kreutzmann, Global AI Deployment Lead, Roche
Oct 714:35
Conference pass
In silico trials
AI in Clinical Trials
Oct 714:35
Conference pass
Donor derived cell free DNA to personalise immunosuppression in transplantation
Precision Medicine, Diagnostics and Therapies
Oct 714:35
Conference pass
Good AI
Image Analysis
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Oct 714:35
Conference pass
Pitfalls on your way to successful lab automation and digitalisation
Lab Automation
Susanne Weissenborn, Team leader Enabling Technologies, Roche
Oct 715:15
Conference pass
Revolutionising Drug Discovery: AI-Powered Identification of Therapeutic Targets
AI in Drug Development and Discovery
Lee Clewley, Senior Director, Head of AI and Informatics, e-therapeutics plc
Oct 715:15
Conference pass
Reimagining Preclinical Systems: Leveraging GenAI and Knowledge Graph Techniques
Digital Transformation
Jobst Loeffler, Product Owner, Bayer
Oct 715:15
Conference pass
Empowering data science across functions with reusable models
Analytics Platform
Philip Gebus, Principal AI Engineer, Bayer
Oct 715:15
Conference pass
The power of AI to improve clinical trials
AI in Clinical Trials
Philipp Pauli, Country Head Oncology Germany, Takeda
Oct 715:15
Conference pass
Simplify and accelerate access to RWD through AI
Real World Evidence
Leonardo D'Ambrosi, Principal Data Scientist, Bayer Pharma AG
Oct 715:15
Conference pass
Novel methylation enrichment technologies for liquid biopsies
Precision Medicine, Diagnostics and Therapies
Oct 715:35
Conference pass
Speaker presentation - Title announced soon!
AI in Clinical Trials
Guillaume Carbonneau, Vice President, Operational Data Insights, Novo Nordisk
Oct 715:35
Conference pass
Stopping people from becoming patients - Harnessing the power of real-world data and omics to predict and preempt disease
Precision Medicine, Diagnostics and Therapies
Lykke Pedersen, Product Creator, Novo Nordisk
Oct 715:55
Conference pass
AI Pharma Agents: Balancing Trust, Reliability and Governance but still fostering new insights
AI in Drug Development and Discovery
Oct 715:55
Conference pass
How we apply behaviour science for transformation implication and cost efficiency
Digital Transformation
Oct 715:55
Conference pass
Data Integration + FAIR from a Roche perspective
Data Integration + FAIR
Roman Engel, Head Agile Document Flow - VPH, Roche
Oct 715:55
Conference pass
AI augmented analytics platforms in peptide optimisation
Analytics Platform
Andrea Possenti, Associate Principal Data Scientist, AstraZeneca
Oct 715:55
Conference pass
High uncertainty Decision making enabled by machine learning models
AI in Clinical Trials
Raul Mora, Senior Development Excellence Lead, Roche
Oct 715:55
Conference pass
Particle control and characterisation in ATMPs
Precision Medicine, Diagnostics and Therapies
John Vergara, Senior Manager, Bristol Myers Squibb
Oct 715:55
Conference pass
How MRI imaging can advance healthcare innovation
Image Analysis
Facundo Calcagno, R&D Transversal Technical Leader, Servier
Oct 716:45
Conference pass
Chair's remarks
AI in Clinical Trials
Philipp Pauli, Country Head Oncology Germany, Takeda
Oct 716:50
Conference pass
AI in Drug Discovery from a BIX perspective
AI in Drug Development and Discovery
Stefaniia legostaieva, Data Scientist, BI X - Digital Lab of Boehringer Ingelheim
Oct 716:50
Conference pass
Increasing engagement with digital health
Digital Transformation
Thomas Boillat, Senior Digital Health Product Lead, Roche
Oct 716:50
Conference pass
Insights in early stage developments
Data Integration + FAIR
Valentina Ranghetti, Customer Insights Lead, Roche
Oct 716:50
Conference pass
Servier’s Analytics Platform: Accelerating Science
Analytics Platform
Yannick Haudry, Lead Data Platform Product Manager, Servier
Oct 716:50
Conference pass
Next level knowledge management in clinical trials
AI in Clinical Trials
Nicola Goetz, Expert Clinical Data Engineer, Boehringer Ingelheim Pharma GmbH & Co KG
Oct 716:50
Conference pass
The World After the 23&Me Hangover: Four Pillars to Rebuild Precision Medicine From the Patient Up
Real World Evidence
Alessandro Riccombeni, CEO, Axia Medicine
Oct 716:50
Conference pass
How to make clinical impact with AI-based prediction algorithms
Precision Medicine, Diagnostics and Therapies
Martin de Borst, Nephrologist and Professor of Medicine, University Medical Centre Groningen
Oct 716:50
Conference pass
Computation pathology in oncology drug development
Image Analysis
Christian Eisen, Director Translational Science, AstraZeneca
Oct 717:10
Conference pass
Speaker presentation - Title announced soon!
AI in Clinical Trials
Abhishek Chatterjee, Head of Product Suite, Senior Director, Novo Nordisk
Oct 717:10
Conference pass
AI for automatic Parkinson’s Disease Voice Assessment
Precision Medicine, Diagnostics and Therapies
Parvaneh Janbakhshi, Data Scientist, Bayer
Oct 717:10
Conference pass
Speaker presentation - Title announced soon!
Image Analysis
Oct 717:30
Conference pass
Panel discussion: The Road Map to Transitioning from Ad-hoc AI to Business Value Generating AI
AI in Drug Development and Discovery
Moderator: Carmen Miguel, Legal Director, Data Privacy, Alnylam
Jeff Milton, Chief Executive Officer, La Jolla Labs
Frederico Braga, Head of Digital and IT, Debiopharm
Oct 717:30
Conference pass
Panel discussion: Women in leadership
Bioinformatics + In silico R&D
Oct 717:30
Conference pass
Panel discussion: The Impact of Digital Transformation on Product Delivery in Healthcare
Digital Transformation
Anastassia Anastassopoulou, Advanced Analytics Strategy Director, Daiichii Sankyo Europe
Nicolas Löffler-Pérez, Data Scientist, Swissmedic
Michele Siccardi, Executive Director, International Insights & Analytics (I&A), CSL Behring
Oct 717:30
Conference pass
Panel discussion: The impact of AI on clinical trials within clinical development
AI in Clinical Trials
Pascal Bouquet, Managing Partner, HealthTechPartners 42
Faisal Khan, Corporate Vice President AI and Analytics, Novo Nordisk
Oct 717:30
Conference pass
Panel discussion: The role of precision medicine in the future of highly-specialized therapies amidst health budget pressures
Precision Medicine, Diagnostics and Therapies
Judy Chou, President and CEO, AltruBio, Inc.
Amit Tiwari, Precision Medicine Brand Lead, Johnson & Johnson
Christophe Dufour, Global Head Digital Precision Medicine, AstraZeneca
Moderator: Ana Filipa Fonseca, Director, Global RLT Strategy & Early Portfolio, Novartis
Create your personal agenda –check the favourite icon
Oct 811:10
Conference pass
AC Immune’s AI in Drug Development approach
AI in Drug Development and Discovery
Anna Gaglianese, Senior Data Scientist, AC Immune SA
Oct 811:10
Conference pass
LLMs inside company
LLMs
Robert Di Giovanni, Senior Global Patient Safety Lead, Novartis
Oct 811:10
Conference pass
Data strategy and Governance in R&D
Digital Transformation
Felipe Albrecht, Principal Scientist, pRED D&A Governance & Strategy, Roche
Oct 811:10
Conference pass
Shape a data-driven future: A Journey towards Data Integration, Data Management, and Organizational Success
Data Integration + FAIR
Oct 811:10
Conference pass
Transforming Analytics for Business Insights: From Standardization to Customization
Analytics Platform
Francesco Orsi, Data Science Manager, Roche
Oct 811:10
Conference pass
LLMs inside company
Lab Automation
Robert Di Giovanni, Senior Global Patient Safety Lead, Novartis
Oct 811:30
Conference pass
Streamling AI / LLM Verification Leveraging Centralized Solutions
LLMs
Mario Sanger, Senior AI / NLP engineer, AstraZeneca
Oct 811:50
Conference pass
AI in Drug Development at Sevier
AI in Drug Development and Discovery
Sofia Lotfi, Senior Data Scientist, Drug Discovery, Servier
Oct 811:50
Conference pass
Information grounding of LLMs using knowledge graphs and documents
LLMs
Nikola Milosevic, Senior Computational Scientist, Bayer
Oct 811:50
Conference pass
Progressive policies on Data and AI to enable Digital Transformation
Digital Transformation
Oct 811:50
Conference pass
From data chaos to competitive edge: Building a winning R&D data strategy
Data Integration + FAIR
Jorine Putter, Senior Director, Data Asset Framework & Services, GSK
Oct 811:50
Conference pass
Pick the right model: chosing the right hiPSC-derived neurons
Analytics Platform
Peter Reinhardt, Principal Research Scientist, AbbVie
Oct 812:10
Conference pass
Open source drug discovery
AI in Drug Development and Discovery
Jake Chen, Endowed Professor and Founding Director, SPARC, University of Alabama at Birmingham
Oct 812:10
Conference pass
Speaker presentation - Title announced soon!
LLMs
Michael Schorpp, Head of Knowledge Management and AI, Boehringer Ingelheim International GmbH
Oct 812:30
Conference pass
Cell painting and multiomics in drug discovery
AI in Drug Development and Discovery
Stefan Platz, Senior Vice President, AstraZeneca
Oct 812:30
Conference pass
Accelerating drug discovery with an AI KG-based Research Assistant chatbot
LLMs
Albert Maristany, Knowledge Graph Product Lead, AstraZeneca
Oct 812:30
Conference pass
Development of a System for ADC Molecular Registration
Data Integration + FAIR
Phin Chooi, Senior Scientist, AstraZeneca
Oct 812:30
Conference pass
OCEAN: Roche’s “FAIR by Design” Analysis Platform Journey (SCE, CDR)
Analytics Platform
Ian Healy, Global Platforms Lead, Roche
Oct 813:45
Conference pass
Keynote panel : Future of AI & technologies in Neurological disorders
Keynotes
Amit Khanna, VP, Global Program HeadParkinson’s & Neuroscience Digital Programs, Novartis
last published: 24/Apr/25 14:25 GMT
Get involved at BioTechX
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events